One patient, Jane, lost over 30 pounds in six months, while John saw a reduction of 25 pounds in just four months
Compounding eligibility changes with FDA shortage status verify current status with a licensed physician and pharmacy at the time of care
Recently, Semaglutide has been approved by the FDA for weight loss in obese and certain overweight patients
Oatzempic Considerations The CDC recommends slow and steady weight loss of 1-2 pounds per week
Average Weight Loss of 15%-20% in Clinical Trials ( source )
Consider MeAgain, an allinone GLP-1 app that complements your medical plan by turning maintenance into a simple, addictive routine with an adorable capybara and a Journey Card that acts like a pocket coach, keeping progress visible